Carmelo Gurnari

3.0k total citations
141 papers, 1.0k citations indexed

About

Carmelo Gurnari is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Carmelo Gurnari has authored 141 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Hematology, 48 papers in Genetics and 43 papers in Molecular Biology. Recurrent topics in Carmelo Gurnari's work include Acute Myeloid Leukemia Research (87 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers) and Chronic Myeloid Leukemia Treatments (21 papers). Carmelo Gurnari is often cited by papers focused on Acute Myeloid Leukemia Research (87 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers) and Chronic Myeloid Leukemia Treatments (21 papers). Carmelo Gurnari collaborates with scholars based in Italy, United States and France. Carmelo Gurnari's co-authors include Jaroslaw P. Maciejewski, Valeria Visconte, Simona Pagliuca, Maria Teresa Voso, Hassan Awada, Eleonora De Bellis, Heesun J. Rogers, Waled Bahaj, Tiziana Ottone and Donal P. McLornan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Communications.

In The Last Decade

Carmelo Gurnari

119 papers receiving 1.0k citations

Peers

Carmelo Gurnari

HEMAT

GENET

IMMUN

RHEUM

Maria Kleppe United States

Radovan Vrḫovac Croatia

A. Brizard France

Paola Masolini Italy

Pinkal Desai United States

S. Faderl United States

I Murohashi Japan

Fumiharu Yagasaki Japan

Ik‐Chan Song South Korea

Isamu Sugiura Japan

Maria Kleppe United States

Carmelo Gurnari

361 ×0.6

HEMAT

459 ×1.3

302 ×0.9

GENET

233 ×1.1

IMMUN

92 ×0.6

RHEUM

Citations per year, relative to Carmelo Gurnari Carmelo Gurnari (= 1×) peers Maria Kleppe

Countries citing papers authored by Carmelo Gurnari

Since Specialization

Citations

This map shows the geographic impact of Carmelo Gurnari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmelo Gurnari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmelo Gurnari more than expected).

Fields of papers citing papers by Carmelo Gurnari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmelo Gurnari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmelo Gurnari. The network helps show where Carmelo Gurnari may publish in the future.

Co-authorship network of co-authors of Carmelo Gurnari

This figure shows the co-authorship network connecting the top 25 collaborators of Carmelo Gurnari. A scholar is included among the top collaborators of Carmelo Gurnari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmelo Gurnari. Carmelo Gurnari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weeks, Lachelle D., Danielle Hammond, Sinisa Savic, et al.. (2025). Establishing a consensus definition of VEXAS flare for clinical research. Lara D. Veeken. 65(2).

Gurnari, Carmelo, Carlos Bravo‐Pérez, Arda Durmaz, et al.. (2025). Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia. Leukemia. 39(3). 748–751. 3 indexed citations

Paterno, Giovangiacinto, Raffaele Palmieri, Carmelo Gurnari, et al.. (2024). The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia. Thrombosis Research. 236. 30–36. 4 indexed citations

Gurnari, Carmelo, et al.. (2024). Allogenic haematopoietic stem cell transplantation in VEXAS: A review of 33 patients. Clinical Rheumatology. 43(11). 3565–3575. 4 indexed citations

Kroger, Benjamin, Roni Tamari, Carmelo Gurnari, et al.. (2024). Prediction of Post-Transplant Relapse of the Myelodysplastic Syndromes Via Evaluation of Stem Cells. Blood. 144(Supplement 1). 777–777.

Bahaj, Waled, Bhavisha A. Patel, Ahmet Toprak, et al.. (2024). Ahemolytic PNH (white cell PNH): Clinical features and implications of a distinct phenotype of paroxysmal nocturnal haemoglobinuria. British Journal of Haematology. 204(5). 2121–2124. 2 indexed citations

Bravo‐Pérez, Carlos, Zoe Brady, Arda Durmaz, et al.. (2024). Budd-Chiari Syndrome: Pathogenetic Factors and Completeness of Screening for Paroxysmal Nocturnal Hemoglobinuria. Blood. 144(Supplement 1). 1254–1254.

Kubota, Yasuo, Carlos Bravo‐Pérez, Carmelo Gurnari, et al.. (2024). Genomic Landscape of Germline RUNX1 variants in Adult Myeloid Neoplasia According to Functional Impact. Blood. 144(Supplement 1). 1328–1328. 1 indexed citations

Travaglini, Serena, Maurizio Fanciulli, Stefano Scalera, et al.. (2024). Evolution of transcriptomic profiles in relapsed inv(16) acute myeloid leukemia. Leukemia Research. 145. 107568–107568. 1 indexed citations

10.

Polverelli, Nicola, Juan Carlos Hernández‐Boluda, Nico Gagelmann, et al.. (2024). Navigating ‘grey areas’ and challenges during evaluation of transplant eligibility in specific myelofibrosis populations: a perspective on behalf of the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation. 60(1). 10–18. 1 indexed citations

11.

Piciocchi, Alfonso, Tiziana Ottone, Emiliano Fabiani, et al.. (2023). Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting. Blood Advances. 7(17). 5122–5131. 11 indexed citations

12.

Bruno, Alessandro, Carmelo Gurnari, Tobias Alexander, John A. Snowden, & Raffaella Greco. (2023). Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation. Journal of Allergy and Clinical Immunology. 151(5). 1204–1214. 19 indexed citations

13.

Kewan, Tariq, Waled Bahaj, Arda Durmaz, et al.. (2023). Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes. Blood. 141(14). 1768–1772. 18 indexed citations

14.

Awada, Hussein, Carmelo Gurnari, Arda Durmaz, et al.. (2022). Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes. International Journal of Molecular Sciences. 23(5). 2802–2802. 10 indexed citations

15.

Hütter, Stephan, Carmelo Gurnari, J. M. Sanchez, et al.. (2022). Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes. Nature Communications. 13(1). 1038–1038. 28 indexed citations

16.

Gurnari, Carmelo & Donal P. McLornan. (2022). Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation. 57(11). 1642–1648. 20 indexed citations

17.

Gurnari, Carmelo, Simona Pagliuca, Lisa Durkin, et al.. (2021). Vacuolization of hematopoietic precursors: an enigma with multiple etiologies. Blood. 137(26). 3685–3689. 54 indexed citations

18.

Chlon, Timothy M., Courtney E. Hershberger, Kathleen Hueneman, et al.. (2021). Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia. Cell stem cell. 28(11). 1966–1981.e6. 57 indexed citations

19.

Kongkiatkamon, Sunisa, Simona Pagliuca, Vera Ademà, et al.. (2021). Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. Leukemia. 36(4). 1185–1188. 3 indexed citations

20.

Pagliuca, Simona, Carmelo Gurnari, Sanghee Hong, et al.. (2021). Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation. JCI Insight. 6(13). 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact